REGENCELL BIOSCIENCE HOLDINGS LIMITED

Autres langues Regencell Bioscience Holdings Limited

Actions

RGC

KYG7487R1002

Marché Fermé - Nasdaq Autres places de cotation 22:30:01 29/05/2024			Varia. 5j.	Varia. 1 janv.
4,7 ^USD	-6,19 %		-6,19 %	-55,24 %

2023	Regencell Bioscience Holdings Limited publie ses résultats pour l'exercice clos le 30 juin 2023	CI
2023	Regencell Bioscience Holdings Limited publie ses résultats pour le semestre clos le 31 décembre 2022	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Regencell Bioscience Holdings Limited Reports Earnings Results for the Full Year Ended June 30, 2023	27/10/23
Regencell Bioscience Holdings Limited Reports Earnings Results for the Half Year Ended December 31, 2022	15/06/23
Regencell Bioscience Holdings Limited Promotes Yat-Pui Au from Senior Vice President to Chief Business Officer	28/02/23
Regencell Bioscience Holdings Limited Announces the Resignation of Yi-Chung Chao as Chief Medical Officer, with Effect from December 28, 2022	22/12/22
Regencell Bioscience Holdings Limited Reports Earnings Results for the Full Year Ended June 30, 2022	31/10/22
Regencell Bioscience Holdings Limited Announces its Standardized Formulae Shows Reduce ADHD and ASD Symptoms in Interim Results of its Second Efficacy Trial	12/09/22
Regencell Bioscience Holdings Limited Reports Earnings Results for the Half Year Ended December 31, 2021	02/06/22
Regencell Bioscience Holdings Limited Announces Additional Earth Efficacy Trial Results Corroborating Effectiveness of Its Investigational Liquid-Formula Rgc-Cov19tm in Eliminating Mild to Moderate Covid-19 Symptoms Within the 6-Day Treatment Period	18/05/22
La formule liquide expérimentale RGC-COV19TM de Regencell Bioscience a démontré son efficacité, chez ses patients recrutés, dans l'élimination des symptômes légers à modérés de la COVID-19 au cours d'une période de traitement de...	18/02/22
Regencell Bioscience’s Investigational Liquid-Formula RGC-COV19 Shows Effectiveness Through Its Enrolled Patients in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-day Treatment Period in its EARTH Efficacy Trial	17/02/22
Regencell Bioscience : Forms Joint Venture to Offer COVID-19 Treatment to Select Asia Pacific Countries	02/09/21
Update: Regencell Bioscience Raises $24.9 Million from IPO -- Shares More Than Triple Amid Heavy Trading Volume	20/08/21
Regencell Bioscience : Says IPO Raised $24.9 Million	20/08/21
Regencell Bioscience Holdings Limited : annonce son introduction en bourse pour un montant de 21,9 millions de dollars	16/07/21
Regencell Bioscience : Hong Kong's Regencell Bioscience Rises in Nasdaq Debut	16/07/21

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Bourse
Actions
Action RGC
Actualités Regencell Bioscience Holdings Limited
Autres langues

-40% Offre à Durée Limitée : Nos abonnements vous guident vers les meilleurs investissements de demain.

PROFITEZ-EN MAINTENANT